Intensified alkylating chemotherapy for patients with oligometastatic breast cancer harboring homologous recombination deficiency: Primary outcomes from the randomized phase III OLIGO study.

Autor: van Ommen-Nijhof A; Department of medical oncology, NKI-AVL, Amsterdam, the Netherlands., Steenbruggen TG; Department of medical oncology, NKI-AVL, Amsterdam, the Netherlands; Department of internal medicine, St Antonius hospital, Nieuwegein, the Netherlands., Wiersma TG; Department of radiotherapy, NKI-AVL, Amsterdam, the Netherlands., Balduzzi S; Department of biometrics, NKI-AVL, Amsterdam, the Netherlands., Daletzakis A; Department of biometrics, NKI-AVL, Amsterdam, the Netherlands., Holtkamp MJ; Department of medical oncology, NKI-AVL, Amsterdam, the Netherlands., Delfos M; Department of medical oncology, NKI-AVL, Amsterdam, the Netherlands., Schot M; Department of medical oncology, NKI-AVL, Amsterdam, the Netherlands., Beelen K; Department of internal medicine, Rijnstate, Arnhem, the Netherlands., Siemerink EJM; Department of internal medicine, Ziekenhuisgroep Twente, Almelo, Hengelo, the Netherlands., Heijns J; Department of internal medicine, Amphia, Breda, the Netherlands., Mandjes IA; Department of biometrics, NKI-AVL, Amsterdam, the Netherlands., Wesseling J; Department of pathology, NKI-AVL, Amsterdam, the Netherlands; Department of pathology, LUMC, Leiden, the Netherlands., Rosenberg EH; Department of pathology, NKI-AVL, Amsterdam, the Netherlands., Vrancken Peeters MJT; Department of surgical oncology, NKI-AVL, Amsterdam, the Netherlands; Department of surgical oncology, Amsterdam University Medical Center, Amsterdam, the Netherlands., Linn SC; Department of medical oncology, NKI-AVL, Amsterdam, the Netherlands; Department of pathology, Utrecht University, Utrecht, the Netherlands., Sonke GS; Department of medical oncology, NKI-AVL, Amsterdam, the Netherlands; Department of medical oncology, Amsterdam University Medical Center, Amsterdam, the Netherlands. Electronic address: g.sonke@nki.nl.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Dec; Vol. 213, pp. 115083. Date of Electronic Publication: 2024 Oct 20.